ZANIOLO, Orietta; BAMFI, Francesco; IANNAZZO, Sergio. Budget impact of rosiglitazone in type 2 diabetes. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 8, n. 1, p. 15–26, 2007. DOI: 10.7175/fe.v8i1.252. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/252. Acesso em: 23 jul. 2025.